VancomycinImmuneSafety Rating 8/10

Primary research areaSerious gram-positive infections

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range15-20 mg/kg every 8-12h IV; oral for C. diff
AdministrationIntravenous or oral
Safety8/10 · FDA-approved
NCAA D1Permitted

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Vancomycin

Mechanism of action

Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan

Safety profile

Nephrotoxicity, ototoxicity, Red Man Syndrome, thrombophlebitis · Decades of use; red man syndrome (infusion rate related); nephro/ototoxicity with monitoring; well-characterized

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Vancomycin

Failed to fetch